As an independent consultancy firm we are supporting biotechs and drug hunters advancing their innovative assets from nonclinical to early clinical development. Investors benefit from our services for critical investment decisions with our unbiased risk/opportunity assessment. We support health care providers to develop and implement clinical decision support tools to treat pediatric cancer patients in a more effective manner.
